Treatment of Orthostatic Intolerance
Public ClinicalTrials.gov record NCT00262470. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00262470
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Satish R. Raj
- Other
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- Abdominal binder Device
- Acetazolamide Drug
- Atomoxetine Drug
- Atomoxetine & Propranolol Drug
- Breathing Device Device
- Clonidine Drug
- Drinking Water Other
- Entacapone Drug
- Entacapone & Propranolol Drug
- IV Saline Procedure
- Indomethacin Drug
- Isosorbide Dinitrate Drug
- Mecamylamine Drug
- Melatonin Dietary Supplement
- Midodrine Drug
- Modafinil Drug
- Modafinil & Propranolol Drug
- NO Drug Other
- Octreotide Drug
- Placebo Radiation
- Propranolol Drug
- Sertraline Drug
- memantine Drug
Device · Drug · Other + 3 more
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 1997
- Primary completion
- Nov 30, 2029
- Completion
- Nov 30, 2029
- Last update posted
- Oct 7, 2025
1997 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt University Autonomic Dysfunction Center | Nashville | Tennessee | 37232-2195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00262470, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 7, 2025 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00262470 live on ClinicalTrials.gov.